Costas Kleanthes Yannakou

10PUBLICATIONS
68CO-AUTHORS
Molecular targetsHaematological tumoursDental materials and equipmentMedical infection agents (incl. prions)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 26, 2025
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics.

Joshua M L Casan, Xiao Jing Ong, Carrie van der Weyden

|Jul 29, 2025
Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell Lymphoma.

Costas Kleanthes Yannakou, Simon Wu, Karthik Rajah

|Jun 18, 2025
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study.

Adrian Minson, Emma Verner, Pratyush Giri

|Dec 19, 2024
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.

Francine M Foss, Youn H Kim, H Miles Prince

|Mar 14, 2024
Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study.

Kate Manos, Leonid Churilov, Andrew Grigg

|Oct 31, 2023
Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom.

Adrian Minson, Nada Hamad, Pietro Di Ciaccio

Pageof 2

Frequent Collaborators

5 joint publications

Nada Hamad

3 joint publications

Henry Miles Prince

3 joint publications

Pietro R Di Ciaccio

2 joint publications

Chan Y Cheah